Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Critical Care
Published in: Critical Care 1/2017

Open Access 01-12-2017 | Review

The future of critical care: renal support in 2027

Authors: William R. Clark, Mauro Neri, Francesco Garzotto, Zaccaria Ricci, Stuart L. Goldstein, Xiaoqiang Ding, Jiarui Xu, Claudio Ronco

Published in: Critical Care | Issue 1/2017

Login to get access

Abstract

Since its inception four decades ago, both the clinical and technologic aspects of continuous renal replacement therapy (CRRT) have evolved substantially. Devices now specifically designed for critically ill patients with acute kidney injury are widely available and the clinical challenges associated with treating this complex patient population continue to be addressed. However, several important questions remain unanswered, leaving doubts in the minds of many clinicians about therapy prescription/delivery and patient management. Specifically, questions surrounding therapy dosing, timing of initiation and termination, fluid management, anticoagulation, drug dosing, and data analytics may lead to inconsistent delivery of CRRT and even reluctance to prescribe it. In this review, we discuss current limitations of CRRT and potential solutions over the next decade from both a patient management and a technology perspective. We also address the issue of sustainability for CRRT and related therapies beyond 2027 and raise several points for consideration.
Literature
1.
Kramer P, Schrader J, Bohnsack W, Grieben G, Grone HJ, Scheler F. Continuous arteriovenous haemofiltration. A new kidney replacement therapy. Proc Eur Dial Transplant Assoc. 1981;18:743–9.PubMed
2.
Ronco C, Brendolan A, Bragantini L, et al. Arteriovenous hemodiafiltration associated with continuous arteriovenous hemofiltration: a combined therapy for acute renal failure in the hypercatabolic patient. Blood Purif. 1987;5(1):33–40.CrossRefPubMed
3.
Ricci Z, Bonello M, Salvatori G, et al. Continuous renal replacement technology: from adaptive technology and early dedicated machines towards flexible multipurpose machine platforms. Blood Purif. 2004;22(3):269–76.CrossRefPubMed
4.
KDIGO Clinical Practice Guideline for Acute Kidney Injury. Modality of renal replacement therapy in AKI. Kidney Int. 2012;2(1):107–10.
5.
Mehta RL. Challenges and pitfalls when implementing renal replacement therapy in the ICU. Crit Care. 2015;19 Suppl 3:S9.PubMedPubMedCentral
6.
Kellum JA, Ronco C. The 17th Acute Disease Quality Initiative International Consensus Conference: introducing precision continuous renal replacement therapy. Blood Purif. 2016;42(3):221–3.CrossRefPubMed
7.
Bagshaw SM, Chakravarthi MR, Ricci Z, on behalf of the ADQI Consensus Group, et al. Precision continuous renal replacement therapy: solute control in continuous renal replacement therapy. Blood Purif. 2016;42(3):238–47.CrossRefPubMed
8.
Rewa OG, Villeneuve PM, Eurich DT, et al. Quality indicators of continuous renal replacement therapy (CRRT) care in critically ill patients: protocol for a systematic review. Syst Rev. 2015;4:102.CrossRefPubMedPubMedCentral
9.
Cruz D, Bellomo R, Kellum JA, de Cal M, Ronco C. The future of extracorporeal support. Crit Care Med. 2008;36(4 Suppl):S243–52.CrossRefPubMed
10.
Clark WR, Garzotto F, Neri M, Lorenzin A, Zaccaria M, Ronco C. Data analytics for continuous renal replacement therapy: historical limitations and recent technology advances. Int J Artif Organs. 2016;39(8):399–406.CrossRefPubMed
11.
Ronco C, Bellomo R, Homel P, et al. Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet. 2000;356(9223):26–30.CrossRefPubMed
12.
Bouman CS, Oudemans-Van Straaten HM, Tijssen JG, Zandstra DF, Kesecioglu J. Effects of early high-volume continuous venovenous hemofiltration on survival and recovery of renal function in intensive care patients with acute renal failure: a prospective, randomized trial. Crit Care Med. 2002;30(10):2205–11.CrossRefPubMed
13.
Saudan P, Niederberger M, De Seigneux S, et al. Adding a dialysis dose to continuous hemofiltration increases survival in patients with acute renal failure. Kidney Int. 2006;70(7):1312–7.CrossRefPubMed
14.
Tolwani AJ, Campbell RC, Stofan BS, Lai KR, Oster RA, Wille KM. Standard versus high-dose CVVHDF for ICU-related acute renal failure. J Am Soc Nephrol. 2008;19(6):1233–8.CrossRefPubMedPubMedCentral
15.
VA/NIH Acute Renal Failure Trial Network, Palevsky PM, Zhang JH, O'Connor TZ, et al. Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med. 2008;359(1):7–20.CrossRef
16.
Replacement Therapy Study Investigators RENAL, Bellomo R, Cass A, Cole L, et al. Intensity of continuous renal-replacement therapy in critically ill patients. N Engl J Med. 2009;361(17):1627–38.CrossRef
17.
Huang Z, Letteri JJ, Clark WR, Ronco C. Operational characteristics of continuous renal replacement therapy modalities used for critically ill patients with acute kidney injury. Int J Artif Organs. 2008;31:525–34.PubMed
18.
Clark WR, Leblanc M, Ricci Z, Ronco C. Quantification and dosing of renal replacement therapy in acute kidney injury: a reappraisal. Blood Purif (accepted for publication).
19.
Gotch FA. The current place of urea kinetic modelling with respect to different dialysis modalities. Nephrol Dial Transplant. 1998;13 Suppl 6:10–4.CrossRefPubMed
20.
Eknoyan G, Beck GJ, Cheung AK, et al. Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med. 2002;347(25):2010–9.CrossRefPubMed
21.
Paniagua R, Amato D, Vonesh E, et al. Effects of increased peritoneal clearances on mortality rates in peritoneal dialysis: ADEMEX, a prospective, randomized, controlled trial. J Am Soc Nephrol. 2002;13(5):1307–20.PubMed
22.
Meijers B, Vanholder R. HEMO revisited: why Kt/Vurea only tells part of the story. J Am Soc Nephrol. 2016;27(11):3235–7.CrossRefPubMed
23.
Claure-Del Granado R, Macedo E, Chertow GM, et al. Effluent volume in continuous renal replacement therapy overestimates the delivered dose of dialysis. Clin J Am Soc Nephrol. 2011;6(3):467–75.CrossRefPubMedPubMedCentral
24.
Cruz D, Bobek I, Lentini P, Soni S, Chionh CY, Ronco C. Machines for continuous renal replacement therapy. Semin Dial. 2009;22(2):123–32.CrossRefPubMed
25.
26.
Kellum JA, Gómez H, Gómez A, Murray P, Ronco C, ADQI XIV Workgroup. XIV Sepsis phenotypes and targets for blood purification in sepsis: the Bogota consensus. Shock. 2016;45(3):242–8.CrossRefPubMed
27.
Vaara ST, Reinikainen M, Wald R, Bagshaw SM, Pettilä V, FINNAKI Study Group. Timing of RRT based on the presence of conventional indications. Clin J Am Soc Nephrol. 2014;9(9):1577–85.CrossRefPubMedPubMedCentral
28.
Zarbock A, Kellum JA, Schmidt C, et al. Effect of early vs delayed initiation of renal replacement therapy on mortality in critically ill patients with acute kidney injury: the ELAIN Randomized Clinical Trial. JAMA. 2016;315(20):2190–9.CrossRefPubMed
29.
Gaudry S, Hajage D, Schortgen F, AKIKI Study Group, et al. Initiation strategies for renal-replacement therapy in the intensive care unit. N Engl J Med. 2016;375(2):122–33.CrossRefPubMed
30.
Wald R, Adhikari NK, Smith OM, Canadian Critical Care Trials Group, et al. Comparison of standard and accelerated initiation of renal replacement therapy in acute kidney injury. Kidney Int. 2015;88(4):897–904.CrossRefPubMed
31.
Macedo E, Mehta RL. When should renal replacement therapy be initiated for acute kidney injury. Semin Dial. 2011;24:132–7.CrossRefPubMed
32.
Ostermann M, Joannidis M, Pani A, Acute Disease Quality Initiative (ADQI) Consensus Group, et al. Patient selection and timing of continuous renal replacement therapy. Blood Purif. 2016;42(3):224–37.CrossRefPubMed
33.
Kellum JA. How can we define recovery after acute kidney injury? Considerations from epidemiology and clinical trial design. Nephron Clin Pract. 2014;127:81–8.CrossRefPubMed
34.
Kellum JA, Sileanu FE, Bihorac A, Hoste EA, Chawla LS. Recovery after acute kidney injury. Am J Respir Crit Care Med. PMID:27635668
35.
Honore PM, Nguyen HB, Gong M, Sapphire and Topaz Investigators, et al. Urinary tissue inhibitor of metalloproteinase-2 and insulin-like growth factor-binding protein 7 for risk stratification of acute kidney injury in patients with sepsis. Crit Care Med. 2016;44(10):1851–60.CrossRefPubMedPubMedCentral
36.
Menon S, Goldstein SL, Mottes T, et al. Urinary biomarker incorporation into the renal angina index early in intensive care unit admission optimizes acute kidney injury prediction in critically ill children: a prospective cohort study. Nephrol Dial Transplant. 2016;31(4):586–94.CrossRefPubMed
37.
Molitoris BA, Reilly ES. Quantifying glomerular filtration rates in acute kidney injury: a requirement for translational success. Semin Nephrol. 2016;36(1):31–41.CrossRefPubMedPubMedCentral
38.
Boyd JH, Forbes J, Nakada T, Walley KR, Russell JA. Fluid resuscitation in septic shock: a positive fluid balance and elevated central venous pressure are associated with increased mortality. Crit Care Med. 2011;39:259–65.CrossRefPubMed
39.
Sutherland SM, Zappitelli M, Alexander SR, et al. Fluid overload and mortality in children receiving continuous renal replacement therapy: the prospective pediatric continuous renal replacement therapy registry. Am J Kidney Dis. 2010;55(2):316–25.CrossRefPubMed
40.
Garzotto F, Ostermann M, Martin-Langerwerf D, et al. The Dose Response Multicentre Investigation on Fluid Assessment (DoReMIFA) in critically ill patients. Crit Care. 2016;20:196.CrossRefPubMedPubMedCentral
41.
Xu J, Shen B, Fang Y, et al. Postoperative fluid overload is a useful predictor of the short-term outcome of renal replacement therapy for acute kidney injury after cardiac surgery. Medicine. 2015;94(33):e1360.CrossRefPubMedPubMedCentral
42.
Marik P, Bellomo R. A rational approach to fluid therapy in sepsis. Br J Anaesth. 2016;116(3):339–49.CrossRefPubMed
43.
Chen H, Wu B, Gong D, Liu Z. Fluid overload at start of continuous renal replacement therapy is associated with poorer clinical condition and outcome: a prospective observational study on the combined use of bioimpedance vector analysis and serum N-terminal pro-B-type natriuretic peptide measurement. Crit Care. 2015;19:135.CrossRefPubMedPubMedCentral
44.
45.
Nolin TD, Aronoff GR, Fissell WH, Kidney Health Initiative, et al. Pharmacokinetic assessment in patients receiving continuous RRT: perspectives from the Kidney Health Initiative. Clin J Am Soc Nephrol. 2015;10(1):159–64.CrossRefPubMed
46.
Bai M, Zhou M, He L, et al. Citrate versus heparin anticoagulation for continuous renal replacement therapy: an updated meta-analysis of RCTs. Intensive Care Med. 2015;41(12):2098–110.CrossRefPubMed
47.
Gattas DJ, Rabjhandari D, Bradford C, et al. A randomized controlled trial of regional citrate vs regional heparin anticoagulation for continuous renal replacement therapy in critically ill adults. Crit Care Med. 2015;43:1622–9.CrossRefPubMed
48.
Szamosfalvi B, Frinak S, Yee J. Sensors and hybrid therapies: a new approach with automated citrate anticoagulation. Blood Purif. 2012;34:80–7.CrossRefPubMed
49.
Shiga H, Hirasawa H, Nishida O, et al. Continuous hemodiafiltration with a cytokine-adsorbing hemofilter in patients with septic shock: a preliminary report. Blood Purif. 2014;38:211–8.CrossRefPubMed
50.
Meier P, Meier R, Turini P, Friolet R, Blanc E. Prolonged catheter survival in patients with acute kidney injury on continuous renal replacement therapy using a less thrombogenic micropatterned polymer modification. Nephrol Dial Transplant. 2011;26(2):628–35.CrossRefPubMed
51.
Mottes T, Owens T, Niedner M, Juno J, Shanley TP, Heung M. Improving delivery of continuous renal replacement therapy: impact of a simulation-based educational intervention. Pediatr Crit Care Med. 2013;14(8):747–54.CrossRefPubMed
52.
Cerda J, Baldwin I, Honore PM, Villa G, Kellum JA, Ronco C, on behalf of the ADQI Consensus Group. Role of technology in continuous renal replacement therapy for the management of critically ill patients: from adoptive technology to precision continuous renal replacement therapy. Blood Purif. 2016;42:248–65.CrossRefPubMed
53.
Kashani K, Herasevich V. Utilities of electronic medical records to improve quality of care for acute kidney injury: past, present, and future. Nephron Clin Prac. 2015;131:92–6.
54.
Schmidt M, Hodgson C, Combes A. Extracorporeal gas exchange for acute respiratory failure in adult patients: a systematic review. Crit Care. 2015;19(1):99.CrossRefPubMedPubMedCentral
55.
Bañares R, Nevens F, Larsen FS, RELIEF study group, et al. Extracorporeal albumin dialysis with the molecular adsorbent recirculating system in acute-on-chronic liver failure: the RELIEF trial. Hepatology. 2013;57(3):1153–62.CrossRefPubMed
56.
Bart BA, Goldsmith SR, Lee KL, for the Heart Failure Clinical Research Network, et al. Ultrafiltration in decompensated heart failure with cardiorenal syndrome. N Engl J Med. 2012;367:2296–2304.CrossRefPubMedPubMedCentral
57.
Kang JH, Super M, Yung CW, et al. An extracorporeal blood-cleansing device for sepsis therapy. Nat Med. 2014;20:1211–22.CrossRefPubMed
58.
Honore PM, Jacobs R, Joannes-Boyau O, et al. Newly designed CRRT membranes for sepsis and SIRS—a pragmatic approach for bedside intensivists summarizing the more recent advances: a systematic review. ASAIO J. 2013;59:99–106.CrossRefPubMed
59.
McCrea K, Ward R, LaRosa SP. Removal of carbapenem-resistant enterobacteriaceae (CRE) from blood by heparin-functional hemoperfusion media. PLoS One. 2014;9(12):e114242.CrossRefPubMedPubMedCentral
60.
Klein DJ, Foster D, Schorr CA, et al. The EUPHRATES trial (Evaluating the Use of Polymyxin B Hemoperfusion in a Randomized controlled trial of Adults Treated for Endotoxemia and Septic shock): study protocol for a randomized controlled trial. Trials. 2014;15:218.CrossRefPubMedPubMedCentral
61.
Ronco C, Davenport A, Gura V. The future of the artificial kidney: moving towards wearable and miniaturized devices. Nefrologia. 2011;31:9–16.PubMed
62.
63.
Fissell WH, Roy S, Davenport A. Achieving more frequent and longer dialysis for the majority: wearable dialysis and implantable artificial kidney devices. Kidney Int. 2013;84(2):256–64.CrossRefPubMed
64.
Ricci Z, Goldstein SL. Pediatric continuous renal replacement therapy. Contrib Nephrol. 2016;187:121–30.PubMed
65.
Ronco C, Garzotto F, Brendolan A, et al. Continuous renal replacement therapy in neonates and small infants: development and first-in-human use of a miniaturised machine (CARPEDIEM). Lancet. 2014;383(9931):1807–13.CrossRefPubMed
66.
Bagshaw SM, Goldstein SL, Ronco C, Kellum JA, ADQI 15 Consensus Group. Acute kidney injury in the era of big data: the 15(th) Consensus Conference of the Acute Dialysis Quality Initiative (ADQI). Can J Kidney Health Dis. 2016;3:5.CrossRefPubMedPubMedCentral
67.
68.
Hoste EA, Kashani K, Gibney N, on behalf of the 15 ADQI Consensus Group, et al. Impact of electronic-alerting of acute kidney injury: workgroup statements from the 15th ADQI Consensus Conference. Can J Kidney Health Dis. 2016;3:10.CrossRefPubMedPubMedCentral
69.
70.
Kerr M, Bedford M, Matthews B, O'Donoghue D. The economic impact of acute kidney injury in England. Nephrol Dial Transplant. 2014;29(7):1362–8.CrossRefPubMed
71.
Ethgen O, Schneider AG, Bagshaw SM, Bellomo R, Kellum JA. Economics of dialysis dependence following renal replacement therapy for critically ill acute kidney injury patients. Nephrol Dial Transplant. 2015;30(1):54–61.CrossRefPubMed
72.
Levante C, Ronco C. The imperative for health economics assessment in acute kidney injury. Blood Purif. 2016;42:I–VI.CrossRefPubMed
73.
Zhu H, Liu L, Song A, et al. Studying on the fairness of health insurance system under the new normal of universal health insurance. Chinese Health Service Manage. 2016;33(7):512–4.
74.
Hoenich NA, Levin R, Ronco C. Water for haemodialysis and related therapies: recent standards and emerging issues. Blood Purif. 2010;29(2):81–5.CrossRefPubMed
75.
Wratten ML, Ghezzi PM. Hemodiafiltration with endogenous reinfusion. Contrib Nephrol. 2007;158:94–102.CrossRefPubMed
76.
Quenot JP, Binquet C, Vinsonneau C, et al. Very high volume hemofiltration with the Cascade system in septic shock patients. Intensive Care Med. 2015;41(12):2111–20.CrossRefPubMed
77.
Wald R, Friedrich JO, Bagshaw SM, et al. Optimal Mode of clearance in critically ill patients with Acute Kidney Injury (OMAKI)—a pilot randomized controlled trial of hemofiltration versus hemodialysis: a Canadian Critical Care Trials Group project. Crit Care. 2012;16(5):R205.CrossRefPubMedPubMedCentral
78.
Kritmetapak K, Peerapornratana S, Srisawat N, et al. The impact of macro-and micronutrients on predicting outcomes of critically ill patients requiring continuous renal replacement therapy. PLoS One. 2016;11(6):e0156634.CrossRefPubMedPubMedCentral
Metadata
Title
The future of critical care: renal support in 2027
Authors
William R. Clark
Mauro Neri
Francesco Garzotto
Zaccaria Ricci
Stuart L. Goldstein
Xiaoqiang Ding
Jiarui Xu
Claudio Ronco
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Critical Care / Issue 1/2017
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/s13054-017-1665-6

Other articles of this Issue 1/2017

Critical Care 1/2017 Go to the issue

Letter

Video vs direct laryngoscopy in the ICU: are we asking the right question?

Research

Retinal arterial blood flow and retinal changes in patients with sepsis: preliminary study using fluorescein angiography

Review

Precision medicine for all? Challenges and opportunities for a precision medicine approach to critical illness

Research

Trials directly comparing alternative spontaneous breathing trial techniques: a systematic review and meta-analysis

Erratum

Erratum to: Resuscitative endovascular balloon occlusion of the aorta versus aortic cross clamping among patients with critical trauma: a nationwide cohort study in Japan

Viewpoint

Individualized perfusion targets in hypoxic ischemic brain injury after cardiac arrest